Homeopathy vs placebo or usual care: Global improvement (Asafoetida + nux vom subgroup)
It is very uncertain whether homeopathy changes global improvement ‐ patients who improved ‐ Asafoetida + nux vom compared with usual care or placebo (very low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Homeopathy vs usual care or placebo Global improvement ‐ patients who improved ‐ Asafoetida + nux vom · patients with treatment of irritable bowel syndrome It is very uncertain whether homeopathy changes global improvement ‐ patients who improved ‐ Asafoetida + nux vom compared with usual care or placebo (very low certainty). Homeopathy for treatment of irritable bowel syndrome (2013) · Cochrane Headline outcomes onlyearlier version CD009710.PUB2, superseded | RR 1.31 [0.8, 2.15] | 1 study · 42 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Homeopathy for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.